Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration

被引:27
|
作者
Antonini, A
Goldwurm, S
Benti, R
Prokisch, H
Ebhardt, M
Cilia, R
Zini, M
Righini, A
Cossu, G
Pezzoli, G
机构
[1] Inst Clin Perfezionamento, Parkinson Inst, I-20126 Milan, Italy
[2] Inst Clin Perfezionamento, Parkinson Inst & Neuroradiol, I-20126 Milan, Italy
[3] IRCCS, Osped Maggiore, Dept Nucl Med, Milan, Italy
[4] GSF, Natl Res Ctr, Inst Human Genet, Neutherberg, Germany
[5] Tech Univ Munich, Inst Human Genet, D-8000 Munich, Germany
[6] AOBS S Michele Gen Hosp, Dept Neurosci, Cagliari, Italy
关键词
PKAN; genetic; DaTSCAN/SPECT; MRI;
D O I
10.1002/mds.20774
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report on it patient with late-onset, pantothenate kinase-associated neurodegeneration (PKAN) who revealed two new heterozygous Mutations at gene testing and showed asymmetric moderately reduced striatal dopamine transporter binding with single photon emission Computed tomography, possibly due to prolonged neuroleptic treatment. These findings expand the genetic and imaging spectrum of this rare disorder. (c) 2005 Movement Disorder Society.
引用
收藏
页码:417 / 418
页数:2
相关论文
共 50 条
  • [1] An atypical case of Pantothenate kinase-associated neurodegeneration presenting as late-onset parkinsonism
    Seo, J. -H.
    Kim, J. -S.
    Song, S. -K.
    Lee, P. H.
    Sohn, Y. H.
    MOVEMENT DISORDERS, 2009, 24 : S423 - S424
  • [2] Neuropsychological functions and psychiatric symptoms in late-onset manifestation of pantothenate kinase-associated neurodegeneration: a clinical case report
    Palmeri, Rosanna
    Lo Buono, Viviana
    Berenati, Matteo
    Caporale, Mina
    Stroscio, Giuseppe
    Di Lorenzo, Giuseppe
    Bramanti, Alessia
    Sorbera, Chiara
    Marino, Silvia
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2020, 130 (05) : 490 - 492
  • [3] Pantothenate kinase associated neurodegeneration (PKAN); An atypical late-onset presentation with genetic confirmation
    Senanayake, B.
    Dassanayake, U.
    Kurian, M.
    De Silva, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [4] Patient and Caregiver Experience With Pantothenate Kinase-Associated Neurodegeneration
    Jinnah, H.
    Lenderking, W.
    Collins, A.
    Escolar, M.
    Klopstock, T.
    Kruer, M.
    Videnovic, A.
    Robichaux-Viehoever, A.
    Swett, L.
    Revicki, D.
    Bender, R.
    Marshall, R.
    MOVEMENT DISORDERS, 2018, 33 : S228 - S228
  • [5] A novel mutation in a patient with pantothenate kinase-associated neurodegeneration
    Saleheen, D
    Nazir, A
    Khanum, S
    Haider, SR
    Frossard, P
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (06) : 578 - 579
  • [6] Clinical heterogeneity of pantothenate kinase-associated neurodegeneration (PKAN)
    Thomas, M
    Hayflick, SJ
    Jankovic, J
    NEUROLOGY, 2002, 58 (07) : A322 - A322
  • [7] Clinical, genetic and neuroimaging studies in two siblings with pantothenate kinase-associated neurodegeneration
    Huang, Y. -C.
    Wu, Y. -R.
    Lee-Chen, G. -J.
    Chen, C. -M.
    MOVEMENT DISORDERS, 2008, 23 (01) : S259 - S259
  • [8] Late-onset cerebellar ataxia revealing a Pantothenate-kinase-associated neurodegeneration
    Laroussi, S.
    Sakka, S.
    Daoud, S.
    Bouattour, N.
    Moalla, K.
    Farhat, N.
    Damak, M.
    Mhiri, C.
    MOVEMENT DISORDERS, 2023, 38 : S510 - S511
  • [9] Atypical pantothenate kinase-associated neurodegeneration with novel genetic mutation
    Israni, Anil V.
    Mandal, Anirban
    NEUROLOGY INDIA, 2017, 65 (04) : 914 - 915
  • [10] Patient and Caregiver Experience With Pantothenate Kinase-Associated Neurodegeneration (PKAN)
    Escolar, M.
    Lenderking, W.
    Collins, A.
    Jinnah, K.
    Klopstock, T.
    Kruer, M.
    Videnovic, A.
    Robichaux-Viehoever, A.
    Swett, L.
    Revicki, D.
    Bender, R.
    Marshall, R.
    ANNALS OF NEUROLOGY, 2018, 84 : S369 - S369